{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:41:40Z","timestamp":1762033300344},"reference-count":24,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bernhard Nocht Center for Clinical Trials"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.05.080","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T16:08:59Z","timestamp":1436026139000},"page":"4141-4145","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers"],"prefix":"10.1016","volume":"33","author":[{"given":"Louise","family":"Roggelin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof D.","family":"Vinnemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Fischer-Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandi T.","family":"Johnson-Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Rolling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd D.","family":"Burchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman F.","family":"Staats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob P.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.080_bib0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1708-8305.2008.00273.x","article-title":"Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas","volume":"16","author":"Whitaker","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0140","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0150","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.vaccine.2013.02.006","article-title":"A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned","volume":"31","author":"Szu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2009.11.051","article-title":"Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever","volume":"28","author":"Froeschle","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2310\/7060.2005.12604","article-title":"et al Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years","volume":"12","author":"Overbosch","year":"2005","journal-title":"J Trav Med"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0170","series-title":"Typhus","author":"DTG","year":"2006"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0175","series-title":"Typhoid\u2014health advise for travelers","author":"HPA","year":"2011"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0180","series-title":"Typhoid fever","author":"CDC","year":"2013"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0185","first-page":"453","article-title":"Pneumonia immunization in older adults: review of vaccine effectiveness and strategies","volume":"7","author":"Assaad","year":"2012","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/erv.11.8","article-title":"Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines","volume":"10","author":"Poolman","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/CVI.00354-09","article-title":"Development of a bead immunoassay to measure Vi polysaccharide-specific serum IgG after vaccination with the Salmonella enterica serovar Typhi Vi polysaccharide","volume":"17","author":"Staats","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"Mar","key":"10.1016\/j.vaccine.2015.05.080_bib0200","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-158-6-201303190-00005","article-title":"GeoSentinel surveillance of illness in returned travelers, 2007\u20132011","volume":"158","author":"Leder","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0205","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1016\/j.vaccine.2010.09.009","article-title":"Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network","volume":"28","author":"Boggild","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/INF.0b013e3180cc2c25","article-title":"Reconsideration of the use of meningococcal polysaccharide vaccine","volume":"26","author":"Granoff","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0215","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","volume":"1","author":"Anwar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"Sep","key":"10.1016\/j.vaccine.2015.05.080_bib0220","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2012.07.051","article-title":"Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination","volume":"30","author":"Pakkanen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0225","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2012.07.051","article-title":"Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination","volume":"30","author":"Pakkanen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0230","series-title":"Typherix\u2014product monograph","author":"GlaxoSmithKline Inc.","year":"2014"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0235","series-title":"Vivotif package insert USA","author":"FDA","year":"2013"},{"key":"10.1016\/j.vaccine.2015.05.080_bib0240","unstructured":"Arzneimittelkompendium der Schweiz, Vivotif Package Insert Switzerland, 2015. Available from \u3008www.compendium.ch\/mpro\/mnr\/26290\/html\/de\u3009 (accessed 2015 Apr 14)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15007537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:25:06Z","timestamp":1566937506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15007537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15007537"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}